Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy – Results of a United Kingdom phase II trial (CNS 2007 04)
European Journal of Cancer2013Vol. 49(18), pp. 3856–3862
Citations Over TimeTop 10% of 2013 papers
Simon Bailey, Andrew Howman, Keith Wheatley, Dee Wherton, N. Boota, Barry Pizer, Darrel R. Fisher, Pamela Kearns, Susan Picton, Frank Saran, M. Gibson, Adam Glaser, Daniel Connolly, Darren Hargrave
Related Papers
- → Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study(2016)178 cited
- → Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial(2023)7 cited
- → Temozolomide for malignant gliomas in British Columbia: A population-based cost-effectiveness analysis(2004)4 cited
- Study on therapeutic effect of temozolomide in malignant intracranial glioma(2004)
- → CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT(2022)